# Novartis names Firmenich CEO as chairman designate of Sandoz
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2023-02-20
Category: NEWS
Category URL: https://financedigest.com/category/news
Meta Title: Novartis appoints Gilbert Ghostine as chairman-designate of
Meta Description: Novartis announced Gilbert Ghostine as chairman-designate of Sandoz, the generics unit to be spun off later this year. Learn more about his new role here.
URL: https://financedigest.com/novartis-names-firmenich-ceo-as-chairman-designate-of-sandoz-2html

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/2023-02-20t063359z1lynxmpej1j04irtroptp4novartis-cancer-prostate-1736814431322-compressed.jpg)

ZURICH (Reuters) – Novartis on Monday announced the appointment of Gilbert Ghostine as [chairman-designate](https://www.financedigest.com/novartis-names-firmenich-ceo-as-chairman-designate-of-sandoz.html) of Sandoz, the generics unit Novartis wants to spin off later this year.

Ghostine has been CEO of Geneva-based Firmenich, the world’s largest privately owned perfume and taste company, since 2014.

He will become the [chairman](https://www.financedigest.com/novartis-names-firmenich-ceo-as-chairman-designate-of-sandoz.html) of the new board at Sandoz, which is to be formed after its spin-off from Novartis in the second half of 2023, subject to final Novartis Board of Directors and shareholder approvals.

(Reporting by John Revill; Editing by Paul Carrel)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---